Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 5, 2001, Pages 1154-1160

  Mundt, Arno J ^a   Murphy, Kevin T ^a   Rotmensch, Jacob ^a   Waggoner, Steven E ^a   Yamada, S Diane ^a   Connell, Philip P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; Radiation therapy; Stage IIIC

Indexed keywords

BIOLOGICAL ORGANS; CYTOLOGY; DISEASES; HORMONES; SURGERY; TUMORS;

BRACHYTHERAPY;

RADIOTHERAPY;

ANTIINFECTIVE AGENT; CISPLATIN; DOXORUBICIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; SMALL INTESTINE OBSTRUCTION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; CHICAGO; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LIFE TABLES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035424797     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01590-5     Document Type: Article

References (37)

1. Cancer statistics 1998
2. Improved outcome in patients treated with postoperative radiation therapy for pathologic Stage I/II endometrial cancer
3. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecol Oncol Group study
4. Paraortic lymph node evaluation in stage I endometrial cancer
5. Survival in patients with paraortic lymph node metastases from endometrial adenocarcinoma clinically confined to the uterus
6. Annual report of the results of treatment in gynecological cancer
7. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence
8. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma
9. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation
10. Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer
11. Role of whole abdominal radiation therapy in the management of endometrial cancer: Prognostic importance of factors indicating peritoneal metastases
12. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecol Oncol Group Study No. 122
13. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: Analysis of treatment outcomes, prognostic variables and failure patterns following adjuvant radiation therapy
14. Analysis of failure patterns in Stage III endometrial carcinoma and therapeutic implications
15. The effect of postsurgical therapy on stage III endometrial carcinoma
16. Irradiation of para-aortic lymph node metastases from carcinoma of the cervix or endometrium
17. Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure
18. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma
19. Endometrial carcinoma: Treatment of positive paraaortic nodes
20. Para-aortic node biopsy in cervical and endometrial cancers: Does it affect survival?
21. Paraaortic lymph node radiotherapy in cancer of the uterine corpus
22. Nonparametric estimation from incomplete observations
23. Evaluation of survival data and two new rank order statistics arising in its consideration
24. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma
25. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer
26. External pelvic radiation therapy in stage IC endometrial carcinoma
27. Surgery and postoperative radiation therapy in stage II endometrial carcinoma
28. Patterns of spread in node-positive cervical cancer: The relationship between local control and distant metastases
29. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: A multivariate analysis
30. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: A dosimetric analysis
31. Intensity modulated whole pelvic radiation therapy in patients with gynecological malignancies
32. Initial clinical experience with intensity modulated whole pelvic radiation therapy in women with gynecologic malignancies
33. Intensity modulated radiation therapy (IMRT) may reduce small bowel, rectum and bladder complications in patients with cervical cancer treated to the pelvis and paraortics area
34. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high risk endometrial carcinoma, stage I and occult stage II: A Gynecol Oncol Group study
35. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer
36. A randomized trial of progestogens in the primary treatment of endometrial carcinoma
37. The relationship of local and distant failure from endometrial cancer: Defining a clinical paradigm